Provided by Tiger Fintech (Singapore) Pte. Ltd.

OmniAb, Inc.

2.24
-0.0700-3.04%
Volume:276.91K
Turnover:619.02K
Market Cap:272.97M
PE:-3.69
High:2.27
Open:2.26
Low:2.21
Close:2.31
Loading ...

OmniAb Inc Q4 REV View $10.1 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
19 Mar

Press Release: OmniAb Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Dow Jones
·
19 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

OmniAb Inc expected to post a loss of 11 cents a share - Earnings Preview

Reuters
·
15 Mar

Press Release: OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

Dow Jones
·
24 Feb

OmniAb to Participate in Two Investor Conferences in March

Business Wire
·
04 Feb

OmniAb Insider Ups Holding During Year

Simply Wall St.
·
27 Jan

Why OmniAb, Inc. (OABI) Is One of the Best Biotech Penny Stocks to Invest in Now?

Insider Monkey
·
31 Dec 2024

With 55% institutional ownership, OmniAb, Inc. (NASDAQ:OABI) is a favorite amongst the big guns

Simply Wall St.
·
22 Dec 2024

OmniAb Technologies Featured in Two Presentations at the 2024 Antibody Engineering & Therapeutics Conference

Business Wire
·
17 Dec 2024

RBC Lowers Price Target on OmniAb to $7 From $8, Keeps Outperform Rating

MT Newswires Live
·
09 Dec 2024

OmniAb Price Target Maintained With a $8.00/Share by Benchmark

Dow Jones
·
14 Nov 2024

OmniAb Third Quarter 2024 Earnings: Misses Expectations

Simply Wall St.
·
14 Nov 2024

Benchmark Co. Remains a Buy on OmniAb (OABI)

TIPRANKS
·
14 Nov 2024

OmniAb Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

OmniAb Down Over 9%, on Pace for Largest Percent Decrease Since November 2022 -- Data Talk

Dow Jones
·
14 Nov 2024

OmniAb Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
13 Nov 2024

OmniAb (OABI) Receives a Buy from RBC Capital

TIPRANKS
·
13 Nov 2024

OmniAb, Inc. (OABI) Reports Q3 Loss, Lags Revenue Estimates

Zacks
·
13 Nov 2024

OmniAb Q3 2024 GAAP EPS $(0.16) Misses $(0.14) Estimate, Sales $4.17M Miss $8.40M Estimate

Benzinga
·
13 Nov 2024